Search results
Erytech (ERYP) Stops Developing Drug in Leukemia, Down 19.6%
Zacks via Yahoo Finance· 2 years agoAfter evaluating the FDA's feedback, Erytech Pharma (ERYP) halts developing its lead candidate in...
Erytech Pharma SA Sponsored ADR (ERYP) Upgraded to Buy: Here's Why
Zacks via Yahoo Finance· 2 years agoErytech Pharma SA Sponsored ADR (ERYP) has been upgraded to a Zacks Rank #2 (Buy), reflecting...
Erytech's Battle With Activist Investor Echoes As Pherecydes Pharma Merger Vote Comes Closer
Benzinga via Yahoo Finance· 11 months agoIn February, Erytech Pharma SA (NASDAQ: ERYP) announced its proposed combination with Pherecydes...
Erytech Pharma Culls Work On Late-Stage Leukemia Asset, Evaluates Partnership Options
Benzinga via Yahoo Finance· 2 years agoErytech Pharma SA (NASDAQ: ERYP) will no longer seek approval for Graspa in hypersensitive acute...